Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
---|
02/12/2008 | CA2090485C Method and apparatus for the rapid synthesis of substrate-bound or free peptides or oligonucleotides, flat material synthesized in this way and the use of such material |
02/07/2008 | WO2008017081A1 Compositions and methods for the modulation of jnk proteins |
02/07/2008 | WO2008016988A1 Methods of nonspecific target capture of nucleic acids |
02/07/2008 | WO2008016909A2 Nucleotide analogs |
02/07/2008 | WO2008016907A1 Nucleotide analogs |
02/07/2008 | WO2008016686A2 Enhanced broad-spectrum uv radiation filters and methods |
02/07/2008 | WO2008015577A2 Sensizitation of cancer cells to therapy using sina targeting genes from the 1p and 19q chromosomal regions |
02/07/2008 | WO2008014979A2 NUCLEIC ACID OF FORMULA (I): GIXmGn, OR (II): CIXmCn, IN PARTICULAR AS AN IMMUNE-STIMULATING AGENT/ADJUVANT |
02/07/2008 | WO2007143245A3 An l-arabinose fermenting yeast |
02/07/2008 | WO2007133831A3 High throughput genome sequencing on dna arrays |
02/07/2008 | WO2007113683A3 Modulation of tc10 function and method of treating glucose metabolic disorders |
02/07/2008 | WO2006091969A3 Predicting chemosensitivity to cytotoxic agents |
02/07/2008 | US20080034455 Production Of A Protein Localized To The Endoplasmic Reticulum Protein Bodies In A Transgenic Plant And Seed |
02/07/2008 | US20080034453 Nucleotide sequences coding maize and/or soybean proteinfor use in genome mapping, identification and analysis; plant breeding |
02/07/2008 | US20080034451 Rice Pollen-Preferential Promoters And Uses Thereof |
02/07/2008 | US20080033161 Method for extracting nucleic acid |
02/07/2008 | US20080033159 Method for small volume nucleic acid synthesis |
02/07/2008 | US20080033158 using two to (n) purification columns to separate full length 5'-DMT-on oligonucleotides with size ranging from 40 to 180-mers from short length 5'-DMT-on oligonucleotides |
02/07/2008 | US20080033157 Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors |
02/07/2008 | US20080033156 Short interfering nucleic acid (siNA) molecule and a polyamine compound having guanidinium, amine, or histidyl end groups and optionally containing polyether groups; biodrug delivery |
02/07/2008 | US20080033061 Cation conducting gabaa receptors and their use |
02/07/2008 | US20080032947 Pka ligands and polynucleotides encoding pka ligands |
02/07/2008 | US20080032946 Method for producing a composite made of oligonucleotides or polynucleotides and hydrophobic biodegradable polymers as well as composite obtained according to the method |
02/07/2008 | US20080032945 2'-modified oligonucleotides |
02/07/2008 | US20080032944 Target Nucleic Acid Of Retrovirus Integration |
02/07/2008 | US20080032942 double-stranded (siNA) molecule that down-regulates expression of a beta-secretase (BACE) gene |
02/07/2008 | US20080032931 Single-chain polypeptide fusion comprising functional binding, translocation and clostridial neurotoxin heavy chain domain for use as therapeutic agents and/or transporter molecules |
02/07/2008 | US20080032930 Single-chain polypeptide fusion comprising functional binding, translocation and clostridial neurotoxin heavy chain domain for use as therapeutic agents and/or transporter molecules |
02/07/2008 | US20080032928 Treatment of mucus hypersecretion |
02/07/2008 | US20080032927 Treatment of development-related disorders |
02/07/2008 | US20080032921 Inducing immune responses to influenza virus using polypeptide and nucleic acid compositions |
02/07/2008 | US20080032920 Macromolecules modified with electrophilic groups and methods of making and using thereof |
02/07/2008 | US20080032919 BMP-7 Variant Compositions, Methods and Uses |
02/07/2008 | US20080032413 Oligonucleotide For Detecting Target Dna Or Rna |
02/07/2008 | US20080032399 Method and kits for preparing multicomponent nucleic acid constructs |
02/07/2008 | US20080032386 Stabilized Proline Transporter |
02/07/2008 | US20080032385 Novel antimicrobial peptide isolated from Penaeus monodon |
02/07/2008 | US20080032369 Isolated nucleic acid molecule encoding an amino acid sequence with beta -ketoacyl-ACP synthase (KS) activity; polyunsaturated fatty acid (PUFA) polyketide synthase (PKS) systems from bacterial microorganisms ; plants and microorganisms that produce lipids |
02/07/2008 | US20080032368 Pufa polyketide synthase systems and uses thereof |
02/07/2008 | US20080032367 Isolated nucleic acid molecule encoding an amino acid sequence with beta -ketoacyl-ACP synthase (KS) activity; polyunsaturated fatty acid (PUFA) polyketide synthase (PKS) systems from bacterial microorganisms; plants and microorganisms that produce lipids |
02/07/2008 | US20080032351 polyunsaturated fatty acid (PUFA) polyketide synthase (PKS) systems having greater flexibility for commercial use; for the production of bioactive molecules of interest |
02/07/2008 | US20080032346 Method of increasing complementarity in a heteroduplex |
02/07/2008 | US20080032340 Peptide motifs for binding avidin or neutravidin |
02/07/2008 | US20080032339 Using transgenic escherichia as bioreactor for producing immunoglobulins specific to streptococcal capsular protein for use in treatment and prevention of bacterial infection |
02/07/2008 | US20080032338 polyunsaturated fatty acid (PUFA) polyketide synthase (PKS) systems having greater flexibility for commercial use; for the production of bioactive molecules of interest |
02/07/2008 | US20080032337 Genetic engineering; analyze the corresponding expression products, elucidate the pathology of diseases associated with the genes, for example hereditary diseases and cancer, and diagnose and treat such diseases |
02/07/2008 | US20080032336 Chemokine receptor materials and methods |
02/07/2008 | US20080032335 Provides polypeptide having wide substrate specificity and having omega 3 fatty acid desaturation activity, which makes efficiently unsaturated bond at omega 3 position, and a polynucleotide coding for the same; by expressing the polypeptide in the organism, mass production of n-3 series PUFAs is enabled |
02/07/2008 | US20080032332 Wound healing agents; anticancer agents; cardiovascular disorders |
02/07/2008 | US20080032323 Nucleic Acid Construct Containing a Nucleic Acid Derived From the Genome of Hepatitis C Virus (Hcv) of Genotype 2A, and a Cell Having Such Nucleic Acid Construct Introduced Therein |
02/07/2008 | US20080032320 Method of Screening Compound Capable of Accelerating or Inhibiting Apoptosis, Apoptosis Accelarator and Apoptosis Inhibitor |
02/07/2008 | US20080032304 FULL-LENGTH cDNA AND POLYPEPTIDES |
02/07/2008 | US20080032300 Lupac Bifunctional Marker and Its Use in Protein Production |
02/07/2008 | US20080032296 Sequences with FabA-like beta -hydroxyacyl-ACP dehydrase (DH) activity; biosynthesis of polyunsaturated fatty acids (PUFAs) |
02/07/2008 | US20080032288 Labeling Reagents, Methods for the Synthesis of Such Reagents and Methods for the Detection of Biological Molecules |
02/07/2008 | US20080032286 Competition Assay for Identifying Modulators of Quadruplex Nucleic Acids |
02/07/2008 | US20080032285 using a replication composition in the form of a tablet, and a detection kit to perform of RT-PCR; highly sensitive assay for that broadly detects most strains of the virus, is rapid, accurate and easily performed |
02/07/2008 | US20080032280 Method and Kits for Detecting Human Cytomegalovirus |
02/07/2008 | US20080031952 Nucleic Acid Comprising a Sequence Encoding a Modified Glutenin Polypeptide |
02/07/2008 | US20080031936 Immunostimulatory nucleic acid molecules |
02/07/2008 | US20080031878 Polypeptides for the Diagnosis and Therapy of Leishamaniasis |
02/07/2008 | US20080031853 treating Hepatitis-C virus; covalently attached to a nonpeptide polyoxyethylene glycol moiety; nucleic acids encoding the polypeptides; reducing the number of copies of a virus in infected cells; drugs/polymer conjugates/ as viricides |
02/07/2008 | US20080030713 Uncaging devices |
02/07/2008 | DE102006035618A1 New nucleic acid useful as immuno-stimulating adjuvant for manufacture of a composition for treatment of cancer diseases e.g. colon carcinomas and infectious diseases e.g. influenza and malaria |
02/07/2008 | CA2660052A1 Compositions and methods for the modulation of jnk proteins |
02/07/2008 | CA2659301A1 Dinucleotide mrna cap analogs |
02/07/2008 | CA2658105A1 Methods of nonspecific target capture of nucleic acids |
02/07/2008 | CA2643136A1 Installation of genomes or partial genomes into cells or cell-like systems |
02/06/2008 | EP1884569A1 Sensitization of cancer cells to therapy using siNA targeting genes from the 1p and 19q chromosomal regions |
02/06/2008 | EP1883709A2 Human micrornas and methods for inhibiting same |
02/06/2008 | EP1883697A2 Polypeptides and biosynthetic pathways for the production of stereoisomers of monatin and their precursors |
02/06/2008 | EP1883427A2 Compositions and methods for studying and treating inflammatory diseases and disorders |
02/06/2008 | EP1651770B1 Promoter molecules for use in plants |
02/06/2008 | CN101120098A Method for nucleic acid analysis |
02/06/2008 | CN101120092A Co-expression of multiple protein chains or subunits |
02/06/2008 | CN101117344A Isolation of rna and DNA from a biological sample |
02/06/2008 | CN100366730C Promoter and plasmid system for genetic engineering |
02/06/2008 | CN100366631C IgG Fc/HIV-gp120/C3d fusion protein |
02/05/2008 | US7326954 Scaffold-organized metal, alloy, semiconductor and/or magnetic clusters and electronic devices made using such clusters |
02/05/2008 | US7326828 Construction of a recombinant DNA construct encoding the phospholipid, in sense or antisense orientation, wherein expression of the recombinant DNA construct results in production of altered levels of the phospholipid |
02/05/2008 | US7326783 Genetic engineering |
02/05/2008 | US7326781 Polynucleotides encoding the human citron kinase polypeptide, BMSNKC—0020/0021 |
02/05/2008 | US7326780 Label (fluorescence-emitting molecule, hapten-containing molecule, protein, or radioactive chemical) attached to N-(2-chloroethyl)-N-methylaminobenzylamino ligand by a spacer forming a neutralized quaternary ammonium group for covalent attachment to DNA, RNA, or siRNA |
02/05/2008 | US7326779 Primers and method of detecting bacteria |
02/05/2008 | US7326773 PRO6493 antibodies |
02/05/2008 | US7326771 Fluorescent proteins from coelentrates (Corynactis californica), genes encoding the proteins and variants, having unique absorption and emission spectra |
02/05/2008 | US7326693 Antisense modulation of c-reactive protein expression |
02/05/2008 | US7326575 Methods and compositions for the preparation and use of fixed-treated cell-lines and tissue in fluorescence in situ hybridization |
02/05/2008 | US7326567 Plasmid system for multigene expression |
02/05/2008 | US7326566 Compositions and methods for screening antimicrobials |
02/05/2008 | US7326557 Increasing intracellular NADPH availability in E. coli |
02/05/2008 | US7326553 Maltose-1-phosphate-producing enzyme |
02/05/2008 | US7326551 Nucleotide sequences coding polypeptide for use in generation of bacteria which generate synthetic fuels |
02/05/2008 | US7326548 starch conversion for producing fermentation products, such as ethanol, and syrups, such as glucose; fusion polypeptide; mixture with alpha-amylase |
02/05/2008 | US7326547 Irradiated plant mutant which generates seed oil with reduced concentrations of polyunsaturated fatty acids |
02/05/2008 | US7326545 Chlamydia antigens and corresponding DNA fragments and uses thereof |
02/05/2008 | US7326544 Reagents for diagnosis of bacterial infection, components of antibacterial vaccines, and/or as targets for antibacterial drugs |
02/05/2008 | US7326543 Gene encoding protein from merozoite of Babesia caballi, recombinant protein obtained with said gene and use thereof |
02/05/2008 | US7326537 In human blood, urine, saliva, tissue biopsy or autopsy material; immunoassay using a mono- or polyclonal antibody; detecting overexpression; diagnosis |
02/05/2008 | US7326533 Amplifying the sequence in vitro in a nucleic acid amplification mixture that includes specific primer sequences, and detecting the amplified sequences using probes that provide information by their specific hybridization to portions of the amplified nucleic acid |